Study guide

15.2 Minor Ailments II: Acne, Dermatitis, Psoriasis, Lice, Scabies & Sun Protection

PEBC Pharmacist Qualifying Examination Part I MCQ

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Canadian Pharmacy Regulatory Framework & Federal Legislation

1.1 Food and Drugs Act, Regulations, and Health Canada Oversight 1.2 Controlled Drugs and Substances Act (CDSA) & Controlled Substances Regulations (CSR) 1.3 NAPRA Drug Scheduling Framework & National Model Standards of Practice

2 Chapter 2: Ethics, Scope of Practice & Safety Culture

2.1 Professional Ethics, Fiduciary Duty & Health Information Privacy 2.2 Expanded Scope of Practice: Minor Ailments Prescribing, Renewals & Injections 2.3 Equity, Diversity, Inclusion, Cultural Safety & Continuous Quality Improvement

3 Chapter 3: Pharmaceutical Calculations & Posology

3.1 Concentrations, Dilutions, Alligations & Reconstitution 3.2 Dosing by Weight/BSA, Days Supply & Pediatric/Geriatric Dose Adjustments 3.3 IV Infusion Rates, Drop Factors, Osmolarity & Creatinine Clearance (Cockcroft-Gault)

4 Chapter 4: Compounding, Dispensing & Product Integrity

4.1 Non-Sterile Compounding & Beyond-Use Dating (NAPRA Standards) 4.2 Sterile Preparations & Hazardous Drug Handling (NAPRA / NIOSH Principles) 4.3 Prescription Verification, Auxiliary Labeling, Cold Chain & Medication Incident Prevention (ISMP Canada) 4.4 Dispensing Operations: Interchangeability, Adjudication, Compliance Packaging, Release & Inventory Control

5 Chapter 5: Clinical Pharmacology & Pharmacokinetics

5.1 Pharmacokinetic Principles: Clearance, Volume of Distribution, Half-life & Steady State 5.2 Cytochrome P450 Enzymes, Transporters & Significant Drug-Drug Interactions 5.3 Therapeutic Drug Monitoring (TDM), Narrow Therapeutic Index Drugs & Toxicities

6 Chapter 6: Evidence-Based Medicine & Literature Appraisal

6.1 Study Designs, Bias & Levels of Evidence in Clinical Research 6.2 Biostatistics: ARR, RRR, NNT, NNH, Confidence Intervals & P-values 6.3 Applying Canadian Practice Guidelines to Clinical Decision-Making 6.4 Drug Information Practice, Diagnostic Test Accuracy & Pharmacoeconomics

7 Chapter 7: Cardiovascular Pharmacotherapy: Hypertension, Dyslipidemia & CAD

7.1 Hypertension Management (Hypertension Canada Guidelines, Targets & Regimens) 7.2 Dyslipidemia & Atherosclerotic Cardiovascular Disease (CCS Guidelines & Statin Therapy) 7.3 Ischemic Heart Disease & Acute Coronary Syndromes (Antiplatelet & Antianginal Therapy)

8 Chapter 8: Cardiovascular Pharmacotherapy: Heart Failure, Arrhythmias & Anticoagulation

8.1 Heart Failure with Reduced & Preserved Ejection Fraction (GDMT & Monitoring) 8.2 Atrial Fibrillation, Arrhythmias & Rate vs. Rhythm Control 8.3 Venous Thromboembolism & Anticoagulation Therapy (DOACs, Warfarin & Thrombosis Canada)

9 Chapter 9: Endocrine & Metabolic Disorders

9.1 Type 2 Diabetes: Glycemic Targets, Non-Insulin Pharmacotherapy (Diabetes Canada) 9.2 Insulin Regimens, Type 1 Diabetes, Hypoglycemia & Diabetic Emergencies (DKA/HHS) 9.3 Thyroid Disorders & Osteoporosis (Diagnostic Parameters & Therapeutic Management)

10 Chapter 10: Respiratory & Gastrointestinal Disorders

10.1 Asthma Management & Exacerbations (CTS Guidelines, Relievers & Controllers) 10.2 Chronic Obstructive Pulmonary Disease (COPD) & Inhaler Delivery Systems 10.3 Gastroesophageal Reflux Disease (GERD), Peptic Ulcer Disease & GI Bleeding 10.4 Lower GI & Liver Disorders: Constipation, Diarrhea, IBS, IBD & Cirrhosis

11 Chapter 11: Infectious Diseases & Antimicrobial Stewardship

11.1 Respiratory Tract Infections: Otitis, Sinusitis, Pharyngitis, CAP & HAP 11.2 Urinary Tract, Skin/Soft Tissue & Sexually Transmitted Infections 11.3 Systemic Infections, Clostridioides difficile & Antimicrobial Stewardship Principles 11.4 HIV Prevention & Treatment, Viral Hepatitis, Tuberculosis & Fungal Infections

12 Chapter 12: Central Nervous System & Mental Health

12.1 Major Depressive Disorder & Anxiety Disorders (First-Line Agents & Safety) 12.2 Bipolar Disorder, Schizophrenia & Psychopharmacology Monitoring 12.3 Epilepsy, Seizure Types, Antiseizure Medications & Neuropathic Pain 12.4 Dementia, Parkinson Disease, Migraine, Insomnia & Restless Legs Syndrome

13 Chapter 13: Special Populations, Pain Management & Substance Use

13.1 Acute & Chronic Pain Management: Multimodal Analgesia & Opioid Stewardship 13.2 Substance Use Disorders: Opioid Agonist Therapy, Harm Reduction & Alcohol Withdrawal 13.3 Special Populations: Pharmacotherapy in Pregnancy, Lactation & Geriatrics (Deprescribing / Beers) 13.4 Palliative Care & Pediatric Pharmacotherapy

14 Chapter 14: Renal, Rheumatologic, Hematologic & Oncology Supportive Care

14.1 Chronic Kidney Disease, Acute Kidney Injury & Electrolyte Disorders 14.2 Osteoarthritis, Rheumatoid Arthritis & Gout 14.3 Anemias & Oncology Supportive Care

15 Chapter 15: Minor Ailments, Dermatology and Women's & Men's Health

15.1 Minor Ailments I: Allergic Rhinitis, Colds & Influenza, Eye and Ear Conditions 15.2 Minor Ailments II: Acne, Dermatitis, Psoriasis, Lice, Scabies & Sun Protection 15.3 Women's & Men's Health: Contraception, Emergency Contraception, Menopause, BPH, ED & Overactive Bladder

16 Chapter 16: Immunization & Health Promotion

16.1 Immunization Practice: NACI Recommendations, Administration, Cold Chain & Adverse Events 16.2 Health Promotion: Smoking Cessation, Weight Management, Screening & Social Determinants of Health

17 Chapter 17: Patient Care Process, Communication & Stewardship

17.1 The Patient Care Process: Assessment, Care Planning & Patient Interviewing 17.2 Patient Education, Device Counselling, Health Literacy & Overcoming Barriers 17.3 Interprofessional Collaboration, Pharmacy Workflow, Team Delegation & Drug Shortage Stewardship

15.2 Minor Ailments II: Acne, Dermatitis, Psoriasis, Lice, Scabies & Sun Protection

Key Takeaways Explain This Topic AI

Acne antibiotics are always combined with benzoyl peroxide, topical retinoids take 6 to 12 weeks, and isotretinoin requires a pregnancy prevention program.

Topical corticosteroid potency is matched to site and severity, and one fingertip unit (about 0.5 g) covers two adult palms.

Topical calcineurin inhibitors are steroid-sparing options for the face and folds, and daily emollients are the foundation of eczema care.

Most head lice products need a second application 7 to 10 days later; unwashable items can be sealed in a plastic bag for 2 weeks.

Scabies is treated with permethrin 5% from the neck down, repeated in 7 days, with all close contacts treated at the same time; itch may persist for 2 to 4 weeks.

Last updated: October 2026

Minor Ailments II: Acne, Dermatitis, Psoriasis, Lice, Scabies & Sun Protection

Skin conditions are visible and distressing, and many are managed with non-prescription products. Good outcomes depend on choosing the right agent and potency, and especially on counselling technique : how much to apply, where, how often and for how long.

1. Acne Vulgaris

Severity Typical lesions Treatment

Mild Comedones, few papules Benzoyl peroxide (BPO) and/or a topical retinoid (adapalene, tretinoin); combination products

Moderate Many papules and pustules Topical combination (retinoid + BPO, or clindamycin + BPO ). Add an oral tetracycline (doxycycline, minocycline) with a topical retinoid/BPO, limited to about 3 months. Hormonal therapy (combined oral contraceptive, spironolactone) for suitable patients

Severe / nodular / scarring Nodules, cysts, scarring Oral isotretinoin under dermatology care

Never use topical or oral antibiotics alone. Always combine them with BPO, which prevents Cutibacterium acnes resistance.

BPO: start with 2.5 to 5% (as effective as 10%, with less irritation). It bleaches fabric and hair .

Retinoids: apply a pea-sized amount at night to the whole affected area. Expect dryness and an initial flare. Results take 6 to 12 weeks. Use sunscreen. Topical tretinoin is avoided in pregnancy.

Tetracyclines: take with a full glass of water, and stay upright for 30 minutes (esophagitis). Separate from calcium, iron and antacids. Photosensitivity. Avoid in pregnancy and under 8 years.

Isotretinoin is highly teratogenic . Canadian monographs require a pregnancy prevention program: two forms of contraception, negative pregnancy tests before, during and after therapy, and usually no more than a 30-day supply at a time. Also monitor lipids, liver tests and mood . Avoid tetracyclines (raised intracranial pressure) and vitamin A supplements, and do not donate blood during treatment.

2. Atopic Dermatitis (Eczema)

Daily emollients are the foundation. Use thick, fragrance-free ointments or creams generously, within minutes of a short lukewarm bath ("soak and seal").

Topical corticosteroids (TCS) treat flares. Match the potency to site and severity :

  • Potency Examples Typical use
  • Low Hydrocortisone 0.5–1% Face, eyelids, skin folds, infants
  • Medium Betamethasone valerate 0.05–0.1%, hydrocortisone valerate 0.2% Trunk and limbs
  • High Mometasone furoate 0.1%, betamethasone dipropionate Thicker or resistant plaques on the body

Very high Clobetasol propionate 0.05% Short courses for palms, soles and thick plaques; not on the face or folds

Fingertip unit (FTU): the amount squeezed from the fingertip to the first crease, about 0.5 g . One FTU covers an area the size of two adult palms . Explaining FTUs counters "steroid phobia" and under-treatment.

Ointments are more occlusive and more potent than creams of the same steroid.

Long-term risks with misuse (skin atrophy, striae, telangiectasia) come from potent steroids on thin skin for long periods . They are not a reason to avoid appropriate use.

Topical calcineurin inhibitors (tacrolimus, pimecrolimus) are steroid-sparing options for the face and folds. Expect transient burning at first.

Moderate to severe disease: dupilumab, oral JAK inhibitors, or phototherapy, under specialist care.

3. Psoriasis and Contact Dermatitis

Plaque psoriasis: a topical corticosteroid combined with a vitamin D analogue (calcipotriol/betamethasone), plus salicylic acid or coal tar for scale. Methotrexate, apremilast and biologics (IL-17, IL-23 or TNF inhibitors) are used for moderate to severe disease.

Drugs that can worsen psoriasis: lithium, beta-blockers, antimalarials, and abrupt withdrawal of systemic steroids.

Contact dermatitis: identify and avoid the irritant or allergen (nickel, fragrances, rubber, neomycin). Use a TCS of suitable potency, and refer widespread or facial reactions.

4. Head Lice

Treat only people with live lice , and check all household members.

Options: permethrin 1% cream rinse, pyrethrins, or non-insecticidal products such as isopropyl myristate/cyclomethicone or dimeticone (physical action, so resistance does not develop). Most products need a second application 7 to 10 days later to kill newly hatched lice. Wet combing with a fine-toothed comb adds benefit.

Environment:

Wash bedding, hats and towels used in the previous 2 days in hot water and dry on a hot cycle.

Items that cannot be washed can be sealed in a plastic bag for 2 weeks .

Not needed: steam-cleaning carpets, fumigating, bleaching surfaces, or cutting the hair.

School: children may return after the first treatment. "No-nit" policies are not recommended.

5. Scabies

Permethrin 5% cream:

Apply to the whole body from the neck down (including the scalp and face in infants and older adults), paying attention to the skin between fingers and toes, the wrists, under the nails, and the genitals.

Leave on for 8 to 14 hours, then wash off.

Repeat in 7 days.

Treat all close contacts at the same time , even without symptoms.

Wash bedding and clothing in hot water, or seal them in a bag for at least 3 days; mites do not survive long off the host.

Itch can persist for 2 to 4 weeks after successful treatment. This is not treatment failure. Antihistamines or a mild TCS can help.

Oral ivermectin is used for crusted scabies or outbreaks.

6. Sun Protection and Photosensitivity

Sunscreen: a broad-spectrum product with SPF 30 or higher , applied generously 15 minutes before exposure and reapplied every 2 hours and after swimming or sweating. Use shade and protective clothing too.

Infants under 6 months should be kept out of direct sun rather than relying on sunscreen.

Photosensitizing drugs need extra protection: tetracyclines, fluoroquinolones, sulfonamides, thiazides, amiodarone, retinoids and some NSAIDs.